Terms: = Lung cancer AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063
1532 results:
1. Metochalcone induces senescence-associated secretory phenotype via JAK2/stat3 pathway in breast cancer.
Zhou J; Wan F; Xiao B; Li X; Peng C; Peng FU
Oncol Res; 2024; 32(5):943-953. PubMed ID: 38686052
[TBL] [Abstract] [Full Text] [Related]
2. TMEM9 promotes lung adenocarcinoma progression via activating the MEK/ERK/stat3 pathway to induce VEGF expression.
Wang Z; Zhao P; Tian K; Qiao Z; Dong H; Li J; Guan Z; Su H; Song Y; Ma X
Cell Death Dis; 2024 Apr; 15(4):295. PubMed ID: 38664392
[TBL] [Abstract] [Full Text] [Related]
3. The endonuclease FEN1 mediates activation of stat3 and facilitates proliferation and metastasis in breast cancer.
Wu M; Huang X; Wu B; Zhu M; Zhu Y; Yu L; Lan T; Liu J
Mol Biol Rep; 2024 Apr; 51(1):553. PubMed ID: 38642158
[TBL] [Abstract] [Full Text] [Related]
4. ANXA9 facilitates S100A4 and promotes breast cancer progression through modulating stat3 pathway.
Zhou X; Zhao J; Yan T; Ye D; Wang Y; Zhou B; Liu D; Wang X; Zheng W; Zheng B; Qian F; Li Y; Li D; Fang L
Cell Death Dis; 2024 Apr; 15(4):260. PubMed ID: 38609357
[TBL] [Abstract] [Full Text] [Related]
5. Chitin-mediated blockade of chitinase-like proteins reduces tumor immunosuppression, inhibits lymphatic metastasis and enhances anti-PD-1 efficacy in complementary TNBC models.
Salembier R; De Haes C; Bellemans J; Demeyere K; Van Den Broeck W; Sanders NN; Van Laere S; Lyons TR; Meyer E; Steenbrugge J
Breast Cancer Res; 2024 Apr; 26(1):63. PubMed ID: 38605414
[TBL] [Abstract] [Full Text] [Related]
6. [High LINC00626 expression promotes esophagogastric junction adenocarcinoma metastasis: the mediating role of the JAK1/stat3/KHSRP axis].
Zhang F; Fan L; Kang X; Wei H; Li L
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Mar; 44(3):541-552. PubMed ID: 38597446
[TBL] [Abstract] [Full Text] [Related]
7. IL-17 induces NSCLC cell migration and invasion by elevating MMP19 gene transcription and expression through the interaction of p300-dependent stat3-K631 acetylation and its Y705-phosphorylation.
Ge W; Li YA; Ruan Y; Wu N; Ma P; Xu T; Shu Y; Wang Y; Qiu W; Zhao C
Oncol Res; 2024; 32(4):625-641. PubMed ID: 38560562
[TBL] [Abstract] [Full Text] [Related]
8. Hexavalent chromium exposure activates the non-canonical nuclear factor kappa B pathway to promote immune checkpoint protein programmed death-ligand 1 expression and lung carcinogenesis.
Wang PS; Liu Z; Sweef O; Saeed AF; Kluz T; Costa M; Shroyer KR; Kondo K; Wang Z; Yang C
Cancer Lett; 2024 May; 589():216827. PubMed ID: 38527692
[TBL] [Abstract] [Full Text] [Related]
9. c-MET pathway in human malignancies and its targeting by natural compounds for cancer therapy.
Mohan CD; Shanmugam MK; Gowda SGS; Chinnathambi A; Rangappa KS; Sethi G
Phytomedicine; 2024 Jun; 128():155379. PubMed ID: 38503157
[TBL] [Abstract] [Full Text] [Related]
10. Anlotinib Inhibits Cisplatin Resistance in Non-Small-Cell lung cancer Cells by Inhibiting MCL-1 Expression via MET/stat3/Akt Pathway.
Wang L; Xu L; Han S; Zhu X
Can Respir J; 2024; 2024():2632014. PubMed ID: 38468814
[TBL] [Abstract] [Full Text] [Related]
11. Emerging role of tumor suppressing microRNAs as therapeutics in managing non-small cell lung cancer.
Singh S; Saxena S; Sharma H; Paudel KR; Chakraborty A; MacLoughlin R; Oliver BG; Gupta G; Negi P; Singh SK; Dua K
Pathol Res Pract; 2024 Apr; 256():155222. PubMed ID: 38452582
[TBL] [Abstract] [Full Text] [Related]
12. IL6-stat3-C/EBPβ-IL6 positive feedback loop in tumor-associated macrophages promotes the EMT and metastasis of lung adenocarcinoma.
Hu Z; Sui Q; Jin X; Shan G; Huang Y; Yi Y; Zeng D; Zhao M; Zhan C; Wang Q; Lin Z; Lu T; Chen Z
J Exp Clin Cancer Res; 2024 Feb; 43(1):63. PubMed ID: 38424624
[TBL] [Abstract] [Full Text] [Related]
13. 5-Methoxytryptophan enhances the sensitivity of sorafenib on the inhibition of proliferation and metastasis for lung cancer cells.
Chen HC; Kuo CY; Chang Y; Tsai DL; Lee MH; Lee JY; Lee HM; Su YC
BMC Cancer; 2024 Feb; 24(1):248. PubMed ID: 38388902
[TBL] [Abstract] [Full Text] [Related]
14. A coumarin-furoxan hybrid as novel nitric oxide donor induced cell apoptosis and ferroptosis in NSCLC by promoting S-nitrosylation of stat3 and negative regulation of JAK2-stat3 pathway.
Cao F; Li M; Wang W; Yi Y; Chen Y; Liu H
Biochem Pharmacol; 2024 Apr; 222():116068. PubMed ID: 38387529
[TBL] [Abstract] [Full Text] [Related]
15. MiR-320a upregulation contributes to the effectiveness of pemetrexed by inhibiting the growth and invasion of human lung cancer cell line (Calu-6).
Ghorbani Alvanegh A; Arpanaei A; Esmaeili Gouvarchin Ghaleh H; Mohammad Ganji S
Mol Biol Rep; 2024 Feb; 51(1):310. PubMed ID: 38372812
[TBL] [Abstract] [Full Text] [Related]
16. Farnesoid X receptor promotes non-small cell lung cancer metastasis by activating Jak2/stat3 signaling via transactivation of IL-6ST and IL-6 genes.
Jin X; Shang B; Wang J; Sun J; Li J; Liang B; Wang X; Su L; You W; Jiang S
Cell Death Dis; 2024 Feb; 15(2):148. PubMed ID: 38360812
[TBL] [Abstract] [Full Text] [Related]
17. Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial.
Besse B; Pons-Tostivint E; Park K; Hartl S; Forde PM; Hochmair MJ; Awad MM; Thomas M; Goss G; Wheatley-Price P; Shepherd FA; Florescu M; Cheema P; Chu QSC; Kim SW; Morgensztern D; Johnson ML; Cousin S; Kim DW; Moskovitz MT; Vicente D; Aronson B; Hobson R; Ambrose HJ; Khosla S; Reddy A; Russell DL; Keddar MR; Conway JP; Barrett JC; Dean E; Kumar R; Dressman M; Jewsbury PJ; Iyer S; Barry ST; Cosaert J; Heymach JV
Nat Med; 2024 Mar; 30(3):716-729. PubMed ID: 38351187
[TBL] [Abstract] [Full Text] [Related]
18. Tumor cell senescence-induced macrophage CD73 expression is a critical metabolic immune checkpoint in the aging tumor microenvironment.
Deng Y; Chen Q; Yang X; Sun Y; Zhang B; Wei W; Deng S; Meng J; Hu Y; Wang Y; Zhang Z; Wen L; Huang F; Wan C; Yang K
Theranostics; 2024; 14(3):1224-1240. PubMed ID: 38323313
[No Abstract] [Full Text] [Related]
19. Antibody-Drug Conjugate αEGFR-E-P125A Reduces Triple-negative Breast cancer Vasculogenic Mimicry, Motility, and Metastasis through Inhibition of EGFR, Integrin, and FAK/stat3 Signaling.
Sankar AP; Cho HM; Shin SU; Sneh T; Ramakrishnan S; Elledge C; Zhang Y; Das R; Gil-Henn H; Rosenblatt JD
Cancer Res Commun; 2024 Mar; 4(3):738-756. PubMed ID: 38315147
[TBL] [Abstract] [Full Text] [Related]
20. Dynamic phenotypic reprogramming and chemoresistance induced by lung fibroblasts in small cell lung cancer.
Lu Y; Li H; Zhao P; Tian L; Liu Y; Sun X; Cheng Y
Sci Rep; 2024 Feb; 14(1):2884. PubMed ID: 38311608
[TBL] [Abstract] [Full Text] [Related]
[Next]